1. Home
  2. ASMB vs NVRI Comparison

ASMB vs NVRI Comparison

Compare ASMB & NVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

N/A

Current Price

$19.95

Market Cap

512.1M

Sector

Health Care

ML Signal

N/A

Logo Enviri Corporation

NVRI

Enviri Corporation

N/A

Current Price

$24.13

Market Cap

582.1M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
ASMB
NVRI
Founded
2005
1853
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
582.1M
IPO Year
2010
2026

Fundamental Metrics

Financial Performance
Metric
ASMB
NVRI
Price
$19.95
$24.13
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
★ $51.20
$33.00
AVG Volume (30 Days)
201.9K
★ 423.1K
Earning Date
11-24-2026
11-05-2026
Dividend Yield
N/A
★ 59.90%
EPS Growth
★ 91.78
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.20
$12.70
52 Week High
$39.71
$25.40

Technical Indicators

Market Signals
Indicator
ASMB
NVRI
Relative Strength Index (RSI) 42.68 68.13
Support Level $19.25 $18.08
Resistance Level $21.65 N/A
Average True Range (ATR) 1.16 1.19
MACD 0.37 0.66
Stochastic Oscillator 26.65 84.94

Price Performance

Historical Comparison
ASMB
NVRI

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About NVRI Enviri Corporation

Enviri Corp provides environmental and operational solutions to the metal and rail industries. It is based in Philadelphia, Pennsylvania, and operates in more than 30 countries. The company leverages industrial expertise to help customers improve operational performance, recover value from byproducts, enhance sustainability, and maintain critical infrastructure. Its divisions are Harsco Environmental and Harsco Rail, which combine deep operational capabilities with technologies and world-wide scale to deliver long-term value for customers, communities, and shareholders.

Share on Social Networks: